One of the most important advances to emerge from the covid-19 pandemic is the ability to measure population health at unprecedented scale and speed. Our study of time trends for long term conditions, ...

In patients with cystic fibrosis, CMTX-101, an immune-enabling antibody therapy, lowered four inflammatory biomarkers and ...

Antifibrotic therapy shows similar efficacy in familial and sporadic IPF, with no significant differences in survival or acute exacerbations. Because familial idiopathic pulmonary fibrosis is ...

NIH funding for pediatric dermatology does not always align with disease burden, as seen in the underfunding of viral skin diseases. Atopic dermatitis received the most NIH funding, reflecting its ...

The physical and psychological burden hereditary angioedema (HAE) imposes on affected individuals is profound. Attacks are painful, disfiguring and potentially life-threatening. Attacks are also often ...

Myasthenia gravis is becoming increasingly common around the world, with a resulting disease burden beset by high health care resource utilization, decreased quality of life, and worsened mental ...

Background/aims Up-to-date, stratified estimates of the number of individuals affected by glaucoma in the UK are lacking.

According to a new meta-analysis, acute-on-chronic liver failure (ACLF) can develop even in patients with previously ...